A84/100

Is L3Harris (LHX) a risky stock?

Sector: Industrials Price: $279.41 Composite: 84/100

As of July 21, 2026, Clavix grades L3Harris (LHX) A for risk, a composite score of 84 out of 100 on an A+ to F scale, which puts LHX in the "low risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind LHX's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how LHX scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
71
News sentimentscored, sourced recent coverage
74
Macro exposuresensitivity to rates, dollar, oil
77
Sector resiliencestrength vs the broad market
61
Price stabilitydrawdown and volatility
48

What's moving LHX's risk right now

Company-specific signals Clavix flags behind LHX's current grade, drawn from recent news and filings as of July 21, 2026.

Demand · supporting the grade

L3Harris secured dual defense awards covering Space Force satellites and Army tactical communications, including a $1.75B SDA missile-defense satellite contract layered on prior wins. The deals add to backlog and strengthen revenue visibility across its space and tactical comms segments.

Product · supporting the grade

L3Harris and Shield AI flew an autonomous electronic warfare drone built through their DiSCO partnership. The successful test moves LHX closer to fielding next-generation defense electronics.

Regulatory · mixed signal

Ongoing Pentagon acquisition reforms could lead to faster contract awards and shorter timelines for L3Harris if the company adapts well. The impact is still speculative and depends on execution.

What a A grade means

On the Clavix A+ to F scale, LHX's composite of 84 falls in the A band (80–100), read as "low risk." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell LHX or any security. Grades are risk indicators, not predictions of return. Data may be delayed.